Search:



The Web

Rediff










Home > Sports > News > Reuters > Report

Young tested positive in Paris

August 08, 2004 19:38 IST

World 400 metres champion Jerome Young tested positive for the banned endurance booster erythropoietin (EPO) at last month's Paris Golden League meeting, French sports daily L'Equipe reported on Sunday.

The newspaper said the American's 'A' sample tested in a Paris laboratory showed traces of the blood-boosting substance. The 'B' sample was sent to another lab in Lausanne.

If the 'B' sample confirms the results of the tests in Paris, 27-year-old Young could face a lifetime ban and may also be stripped of his world title.

The tests were performed during the International Association of Athletics Federations (IAAF) Paris meeting at the Stade de France on July 23, where Young came sixth. The IAAF could not be reached for comment on Sunday morning.

Young, who failed to qualify for the Athens Olympics, had already tested positive for the banned anabolic steroid nandrolone in 1999.

However, he was cleared by the American governing body USA Track & Field (USATF) and competed at the Olympics in Sydney where he won a gold medal as a member of the 4x400 metres relay team that included five-times Olympic champion Michael Johnson.

The IAAF annulled the U.S. result last month but the International Olympic Committee (IOC) said on Saturday it was still waiting for that decision to be "final and enforceable" before deciding on a redistribution of the medals.

Young's compatriot Kelli White was stripped of her 100 and 200 metres world championship gold medals and suspended for two years after she confessed to having used EPO.



Article Tools
Email this article
Top emailed links
Print this article
Write us a letter
Discuss this article



Related Stories


Maurice Greene beaten in Paris

IAAF to review Edwards case

Grimes fails doping test








© Copyright 2004 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.










Copyright © 2004 rediff.com India Limited. All Rights Reserved.